相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Peganine hydrochloride dihydrate an orally active antileishmanial agent
Tanvir Khaliq et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Developments in the treatment of visceral leishmaniasis
Margriet Leontine den Boer et al.
EXPERT OPINION ON EMERGING DRUGS (2009)
N-(2-hydroxypropyl)methacrylamide-amphotericin B (HPMA-AmB) copolymer conjugates as antileishmanial agents
Salvatore Nicoletti et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Antileishmanial activity, pharmacokinetics and tissue distribution studies of mannose-grafted amphotericin B lipid nanospheres
Prabhakar Reddy Veerareddy et al.
JOURNAL OF DRUG TARGETING (2009)
Pentavalent Antimonials: New Perspectives for Old Drugs
Frederic Frezard et al.
MOLECULES (2009)
Reduced tissue parasitic load and infectivity to sand flies in dogs naturally infected by Leishmania (Leishmania) chagasi following treatment with a liposome formulation of meglumine antimoniate
Raul R. Ribeiro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
New treatment approach in Indian visceral leishmaniasis: Single-dose liposomal amphotericin B followed by short-course oral miltefosine
Shyam Sundar et al.
CLINICAL INFECTIOUS DISEASES (2008)
Discovery of Novel Vaccine Candidates and Drug Targets Against Visceral Leishmaniasis Using Proteomics and Transcriptomics
Shraddha Kumari et al.
CURRENT DRUG TARGETS (2008)
Drug delivery systems against leishmaniasis? Still an open question
Eder L. Romero et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Antileishmanial activity mediated by apoptosis and structure-based target study of peganine hydrochloride dihydrate: an approach for rational drug design
Pragya Misra et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Antileishmanial activity of nano-amphotericin B deoxycholate
Krishna Das Manandhar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Complete cure of experimental visceral leishmaniasis with amphotericin B in stearylamine-bearing cationic liposomes involves down-regulation of IL-10 and favorable T cell responses
Antara Banerjee et al.
JOURNAL OF IMMUNOLOGY (2008)
New insights into the chemical structure and composition of the pentavalent antimonial drugs, meglumine antimonate and sodium stibogluconate
Frederic Frezard et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2008)
An ethanolic extract of leaves of Piper betle (Paan) Linn mediates its antileishmanial activity via apoptosis
Avijit Sarkar et al.
PARASITOLOGY RESEARCH (2008)
Evaluation of antileishmanial potential of Tinospora sinensis against experimental visceral leishmaniasis
Nasib Singh et al.
PARASITOLOGY RESEARCH (2008)
In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum
Lara Ordonez-Gutierrez et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Racemoside A, an anti-leishmanial, water-soluble, natural steroidal saponin, induces programmed cell death in Leishmania donovani
Avijit Dutta et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2007)
Injectable paromomycin for visceral leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Aloe vera leaf exudate induces a caspase-independent cell death in Leishmania donovani promastigotes
Avijit Dutta et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2007)
In vitro antiprotozoal activities and cytotoxicity of some selected Cameroonian medicinal plants
B. Ndjakou Lenta et al.
JOURNAL OF ETHNOPHARMACOLOGY (2007)
Development and characterization of amphotericin B bearing emulsomes for passive and active macrophage targeting
Swati Gupta et al.
JOURNAL OF DRUG TARGETING (2007)
Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis
Swati Gupta et al.
JOURNAL OF DRUG TARGETING (2007)
In vitro and in vivo leishmanicidal activity of Dysoxylum binectariferum and its fractions against Leishmania donovani
V. Lakshmi et al.
PHYTOMEDICINE (2007)
Chemotherapy of leishmaniasis: Past, present and future
Jyotsna Mishra et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Antileishmanial activity of quinovic acid glycosides and cadambine acid isolated from Naudea diderrichii
Carole Di Giorgio et al.
PLANTA MEDICA (2006)
Liposomal amphotericin B for the treatment of visceral leishmaniasis
Caryn Bern et al.
CLINICAL INFECTIOUS DISEASES (2006)
Improved targeting of antimony to the bone marrow of dogs using liposomes of reduced size
Dante A. Schettini et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Critical evaluation of the therapeutic potential of bassic acid incorporated in oil-in-water microemulsions and poly-D,L-lactide nanoparticles against experimental leishmaniasis
Sanchaita Lala et al.
JOURNAL OF DRUG TARGETING (2006)
Optimizing efficacy of amphotericin B through nanomodification
Suresh P. Vyas et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2006)
Pharmacokinetic and parasitological evaluation of the bone marrow of dogs with visceral leishmaniasis submitted to multiple dose treatment with liposome-encapsulated meglumine antimoniate
DA Schettini et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2005)
Targeting of mannosylated liposome incorporated benzyl derivative of Penicillium nigricans derived compound MT81 to reticuloendothelial systems for the treatment of visceral leishmaniasis
M Mitra et al.
JOURNAL OF DRUG TARGETING (2005)
Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models
A Dube et al.
PARASITOLOGY RESEARCH (2005)
Efficacy of Desmodium gangeticum extract and its fractions against experimental visceral leishmaniasis
N Singh et al.
JOURNAL OF ETHNOPHARMACOLOGY (2005)
Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis
R Tyagi et al.
JOURNAL OF DRUG TARGETING (2005)
Harmine: Evaluation of its antileishmanial properties in various vesicular delivery systems
S Lala et al.
JOURNAL OF DRUG TARGETING (2004)
Targeting of parasite-specific immunoliposome-encapsulated doxorubicin in the treatment of experimental visceral leishmaniasis
S Mukherjee et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Antileishmanial activity of isolated triterpenoids from Pourouma guianensis
EC Torres-Santos et al.
PHYTOMEDICINE (2004)
Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India
SK Bhattacharya et al.
CLINICAL INFECTIOUS DISEASES (2004)
Targetable water-soluble polymer-drug conjugates for the treatment of visceral leishmaniasis
A Nan et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani
S Wyllie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres
JA Sánchez-Brunete et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c mice
S Pal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Anti-leishmanial activity of a new formulation of amphotericin B
MA Dea-Ayuela et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2004)
Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases
KV Rao et al.
JOURNAL OF NATURAL PRODUCTS (2004)
In vitro and in vivo activities of a triterpenoid saponin extract (PX-6518) from the plant Maesa balansae against visceral Leishmania species
L Maes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Comparative activities of the triterpene saponin maesabalide III and liposomal amphotericin B (AmBisome) against Leishmania donovani in hamsters
L Maes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Screening of plant extracts for antiprotozoal and cytotoxic activities
MR Camacho et al.
JOURNAL OF ETHNOPHARMACOLOGY (2003)
Liposome-based approaches to overcome anticancer drug resistance
C Mamot et al.
DRUG RESISTANCE UPDATES (2003)
Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: A multicenter study
S Sundar et al.
CLINICAL INFECTIOUS DISEASES (2003)
Pharmacokinetics, toxicities, and efficacies of sodium stibogluconate formulations after intravenous administration in animals
J Nieto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Antiparasitic alkaloids from Psychotria klugii
I Muhammad et al.
JOURNAL OF NATURAL PRODUCTS (2003)
Pentamidine uptake and resistance in pathogenic protozoa: past, present and future
PG Bray et al.
TRENDS IN PARASITOLOGY (2003)
Trypanocidal and leishmanicidal properties of substitution-containing chalcones
F Lunardi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Therapeutic evaluation of free and nanocapsule-encapsulated atovaquone in the treatment of murine visceral leishmaniasis
E Cauchetier et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2003)
Advances in the treatment of leishmaniasis
S Sundar et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2002)
Oral miltefosine for Indian visceral leishmaniasis
S Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Design and antileishmanial activity of amphotericin B-loaded stable ionic amphiphile biovector formulations
PM Loiseau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Methotrexate conjugate with branched polypeptide influences Leishmania donovani infection in vitro and in experimental animals
G Kóczán et al.
BIOCONJUGATE CHEMISTRY (2002)
Targeting to macrophages:: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages
FL Ahsan et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH3 (edelfosine) and amphotericin B
P Escobar et al.
ACTA TROPICA (2002)
Superior chemotherapeutic efficacy of amphotericin B in tuftsin-bearing liposomes against Leishmania donovani infection in hamsters
AK Agrawal et al.
JOURNAL OF DRUG TARGETING (2002)
Quercetin: Critical evaluation as an antileishmanial agent in vivo in hamsters using different vesicular delivery modes
S Sarkar et al.
JOURNAL OF DRUG TARGETING (2002)
In vitro antileishmanial activity of amphotericin B loaded in poly(epsilon-caprolactone) nanospheres
MS Espuelas et al.
JOURNAL OF DRUG TARGETING (2002)
Antiprotozoal activities of Colombian plants
B Weniger et al.
JOURNAL OF ETHNOPHARMACOLOGY (2001)
Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani
KC Carter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
A policy for leishmaniasis with respect to the prevention and control of drug resistance
A Bryceson
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)
Treatment of visceral leishmaniasis
S Sundar
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2001)
Leishmanicidal, antiplasmodial, and cytotoxic activity of novel diterpenoid 1,2-quinones from Perovskia abrotanoides:: New source of tanshinones
M Sairafianpour et al.
JOURNAL OF NATURAL PRODUCTS (2001)
New sesquiterpene lactones from Elephantopus mollis and their leishmanicidal activities
H Fuchino et al.
PLANTA MEDICA (2001)
Treatment of visceral leishmaniasis with sterically stabilized liposomes containing camptothecin
ME Proulx et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Function and assembly of the Leishmania surface coat
SC Ilgoutz et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2001)
Inhibition of fumarate reductase in Leishmania major and L-donovani by chalcones
M Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Immunomodulatory principles of Pelargonium sidoides
O Kayser et al.
PHYTOTHERAPY RESEARCH (2001)
Plant natural products with leishmanicidal activity
MJ Chan-Bacab et al.
NATURAL PRODUCT REPORTS (2001)
Anti-leishmanial activity of neolignans from Virola species and synthetic analogues
LES Barata et al.
PHYTOCHEMISTRY (2000)
Biodistribution of amphotericin B when delivered through cholesterol hemisuccinate vesicles in normal and A-fumigatus infected mice
S Saxena et al.
PHARMACEUTICAL RESEARCH (2000)
Bisbenzylisoquinoline alkaloids from Guatteria boliviana (Annonaceae)
V Mahiou et al.
PHYTOCHEMISTRY (2000)
A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis
CP Thakur et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2000)
Antileishmanial activities of stearylamine-bearing liposomes
T Dey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Ligation of Fc receptor of macrophages stimulates protein kinase C and antileishmanial activity
D Daasgupta et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2000)
Oxoaporphine alkaloids and quinones from Stephania dinklagei and evaluation of their antiprotozoal activities
MD Camacho et al.
PLANTA MEDICA (2000)
Antileishmanial activity of three saponins isolated from ivy, α-hederin, β-hederin and hederacolchiside A1, as compared to their action on mammalian cells cultured in vitro
F Delmas et al.
PLANTA MEDICA (2000)
Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis
E Cauchetier et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2000)
In vitro and in vivo efficacy of acid-sensitive transferrin and albumin doxorubicin conjugates in a human xenograft panel and in the MDA-MB-435 mamma carcinoma model
F Kratz et al.
JOURNAL OF DRUG TARGETING (2000)
New trichothecenes isolated from Holarrhena floribunda
A Loukaci et al.
JOURNAL OF NATURAL PRODUCTS (2000)
Absolute configuration and antiprotozoal activity of minquartynoic acid
HB Rasmussen et al.
JOURNAL OF NATURAL PRODUCTS (2000)
分享论文
